Future prospects for vaccination of dogs and cats
Squires, Richard (2006) Future prospects for vaccination of dogs and cats. In: Proceedings of the 49th Annual Congress of British Small Animal Veterinary Association, pp. 1-2. From: 49th Annual Congress of British Small Animal Veterinary Association, 20-23 April 2006, Birmingham, UK.
PDF (Published Version)
- Published Version
Veterinarians in clinical practice are quite familiar with the characteristics of inactivated and modified-live vaccines intended to help protect dogs and cats against bacterial and viral infectious diseases. Indeed, generations of veterinary students have been required to learn the relative advantages and disadvantages of inactivated (i.e., killed) and modified-live (i.e., attenuated) vaccines. Most of the vaccines currently available for use in dogs and cats can be placed into one or other of these two 'conventional' categories, although it is perhaps a little unfair to lump them together and describe them as conventional, since some are relatively sophisticated (e.g., a modified-live, temperature sensitive mutant virus). Relatively few currently-available canine and feline vaccines are based on recombinant DNA technology. However, it seems likely that—over the next few years—a startling profusion of novel vaccines will be marketed for use in cats and dogs. Most of these will be based on recombinant DNA technology and not all of them will be prophylactic; some will most likely be therapeutic.
|Item Type:||Conference Item (Non-Refereed Research Paper)|
|Date Deposited:||13 Oct 2011 07:30|
|FoR Codes:||07 AGRICULTURAL AND VETERINARY SCIENCES > 0707 Veterinary Sciences > 070706 Veterinary Medicine @ 100%|
|SEO Codes:||86 MANUFACTURING > 8609 Veterinary Pharmaceutical Products > 860901 Veterinary Biological Preventatives (e.g. Vaccines) @ 100%|
Available Versions of this Item
- Future prospects for vaccination of dogs and cats. (deposited 13 Oct 2011 07:30) [Currently Displayed]